As of 2025-07-02, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (235.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 37.30 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -730.6%.
The range of the Relative Valuation is (166.89) - (328.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 18.2x | 12.8x |
| Forward P/E multiples | 9.3x - 20.7x | 13.3x |
| Fair Price | (166.89) - (328.01) | (235.20) |
| Upside | -547.4% - -979.4% | -730.6% |
| Date | P/E |
| 2025-06-27 | -1.94 |
| 2025-06-26 | -1.97 |
| 2025-06-25 | -1.89 |
| 2025-06-24 | -1.98 |
| 2025-06-23 | -1.82 |
| 2025-06-20 | -1.80 |
| 2025-06-18 | -1.90 |
| 2025-06-17 | -1.94 |
| 2025-06-16 | -2.05 |
| 2025-06-13 | -1.77 |
| 2025-06-12 | -1.92 |
| 2025-06-11 | -2.09 |
| 2025-06-10 | -2.09 |
| 2025-06-09 | -2.18 |
| 2025-06-06 | -2.26 |
| 2025-06-05 | -2.13 |
| 2025-06-04 | -2.16 |
| 2025-06-03 | -2.24 |
| 2025-06-02 | -2.11 |
| 2025-05-30 | -2.21 |
| 2025-05-29 | -2.33 |
| 2025-05-28 | -2.09 |
| 2025-05-27 | -2.05 |
| 2025-05-23 | -1.61 |
| 2025-05-22 | -1.46 |
| 2025-05-21 | -1.57 |
| 2025-05-20 | -1.66 |
| 2025-05-19 | -1.48 |
| 2025-05-16 | -1.55 |
| 2025-05-15 | -1.28 |
| 2025-05-14 | -1.23 |
| 2025-05-13 | -1.12 |
| 2025-05-12 | -1.06 |
| 2025-05-09 | -1.04 |
| 2025-05-08 | -1.05 |
| 2025-05-07 | -1.06 |
| 2025-05-06 | -1.05 |
| 2025-05-05 | -1.09 |
| 2025-05-02 | -1.11 |
| 2025-05-01 | -1.00 |
| 2025-04-30 | -1.00 |
| 2025-04-29 | -0.97 |
| 2025-04-28 | -0.94 |
| 2025-04-25 | -0.99 |
| 2025-04-24 | -0.95 |
| 2025-04-23 | -0.94 |
| 2025-04-22 | -0.83 |
| 2025-04-21 | -0.83 |
| 2025-04-17 | -0.87 |
| 2025-04-16 | -0.88 |